tiprankstipranks
Neovacs SA (DE:0LW)
:0LW
Germany Market
Holding DE:0LW?
Track your performance easily

Neovacs SA (0LW) Financial Statements

0 Followers

Neovacs SA Financial Overview

Neovacs SA's market cap is currently ―. The company's EPS TTM is €-160192.5; its P/E ratio is ―; Neovacs SA is scheduled to report earnings on March 31, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Dec 21Jun 21
Income Statement-
Total Revenue$ 1.45M$ 923.31K-$ 759.12K-
Gross Profit$ 1.19M$ 703.28K-$ 549.77K-
EBIT$ -13.46M$ -7.80M-$ -15.40M-
EBITDA$ -12.42M$ -6.68M---
Net Income Common Stockholders$ -13.84M$ -8.23M-$ -6.15M-
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 25.79M$ 31.25M$ 32.88M$ 51.54M$ 35.78M
Total Assets$ 38.73M$ 44.58M$ 51.20M$ 66.22M$ 37.83M
Total Debt$ 363.40K$ 424.92K$ 2.09M$ 8.96M$ 184.09K
Net Debt$ -25.43M$ -30.83M$ -30.79M$ -42.58M$ -35.59M
Total Liabilities$ 22.89M$ 16.51M$ 4.61M$ 14.00M$ 1.99M
Stockholders Equity$ 15.84M$ 28.06M$ 46.59M$ 52.23M$ 35.83M
Cash Flow-
Free Cash Flow$ -5.39M$ -6.30M-$ -4.39M-
Operating Cash Flow$ -5.39M$ -6.30M-$ -4.39M-
Investing Cash Flow-$ -4.14K-$ -18.02K-
Financing Cash Flow$ -72.54K$ -74.73K-$ 114.07K-
Currency in USD

Neovacs SA Earnings and Revenue History

Neovacs SA Debt to Assets

Neovacs SA Cash Flow

Neovacs SA Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis